Breakdown of private vaccine market in India 2015-2019, by foreign and domestic firms
In 2019, multinational corporations led the private vaccine market in India with a 63 percent market share. While Indian companies provide the bulk of vaccines used in the country's "Universal Immunisation Program," higher priced human papillomavirus, pneumococcal, influenza, and meningococcal vaccines led to multinational corporations dominating the market in terms of value.
